Rivastigmine patches: line extension. No therapeutic advantage and less convenient than capsules.
D000279:Administration, Cutaneous; D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005602:France; D006801:Humans; D048448:Phenylcarbamates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D002800:Cholinesterase Inhibitors; D048448:Phenylcarbamates